| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Pradip Ghosh | Q102215245 |
| Nathaniel Wilganowski | Q123267490 | ||
| Sukhen Ghosh | Q123267498 | ||
| Ali Azhdarinia | Q88542352 | ||
| Eva M. Sevick-Muraca | Q89876807 | ||
| P2860 | cites work | Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer | Q22065848 |
| Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe | Q22065849 | ||
| Isolation of rare circulating tumour cells in cancer patients by microchip technology | Q24597164 | ||
| EpCAM (CD326) finding its role in cancer | Q24653692 | ||
| Exogenous Molecular Probes for Targeted Imaging in Cancer: Focus on Multi-modal Imaging | Q30472127 | ||
| Detection of breast cancer microcalcifications using a dual-modality SPECT/NIR fluorescent probe | Q30488214 | ||
| Fast 18F Labeling of a Near-Infrared Fluorophore Enables Positron Emission Tomography and Optical Imaging of Sentinel Lymph Nodes | Q30497061 | ||
| Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study | Q30503945 | ||
| Near-Infrared Fluorescence Imaging in Humans with Indocyanine Green: A Review and Update | Q30524322 | ||
| Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer | Q33296967 | ||
| Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope | Q33358010 | ||
| Spectral characterization of a novel near-infrared cyanine dye: a study of its complexation with metal ions | Q33380874 | ||
| Toward preparation of antibody-based imaging probe libraries for dual-modality positron emission tomography and fluorescence imaging | Q33464006 | ||
| Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics | Q33816185 | ||
| Near infrared fluorescent optical imaging for nodal staging | Q34038991 | ||
| Complementary optical and nuclear imaging of caspase-3 activity using combined activatable and radio-labeled multimodality molecular probe | Q34043927 | ||
| Detection of Cancer Metastases with a Dual-labeled Near-Infrared/Position Emission Tomography Imaging Agent | Q34111208 | ||
| Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats | Q34300516 | ||
| A self-assembled multimodal complex for combined pre- and intraoperative imaging of the sentinel lymph node. | Q50544550 | ||
| A fully automated synthesis for the preparation of 68Ga-labelled peptides. | Q50902061 | ||
| Role of higher-order scattering in solutions to the forward and inverse optical-imaging problems in random media. | Q51893456 | ||
| A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain. | Q53498275 | ||
| Monomolecular Multimodal Fluorescence-Radioisotope Imaging Agents | Q57273400 | ||
| USE OF TWO EPITHELIUM-SPECIFIC MONOCLONAL ANTIBODIES FOR DIAGNOSIS OF MALIGNANCY IN SEROUS EFFUSIONS | Q57337283 | ||
| Comparison of Four Bifunctional Chelates for Radiolabeling Monoclonal Antibodies with Copper Radioisotopes: Biodistribution and Metabolism | Q58821451 | ||
| Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin | Q69367315 | ||
| Physiochemical studies of indocyanine green (ICG): absorbance/concentration relationship, pH tolerance and assay precision in various solvents | Q70540853 | ||
| The in vivo behavior of copper-64-labeled azamacrocyclic complexes | Q77342598 | ||
| Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions | Q82959566 | ||
| Marked response to single agent trastuzumab in a patient with metastatic HER-2 gene amplified rectal cancer | Q84419743 | ||
| Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody | Q34545866 | ||
| Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes--a systematic review | Q34631121 | ||
| Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT | Q34912643 | ||
| Image-Guided Surgery Using Invisible Near-Infrared Light: Fundamentals of Clinical Translation | Q35017959 | ||
| Matrix remodeling during endochondral ossification | Q35753177 | ||
| Multimodality molecular imaging with combined optical and SPECT/PET modalities | Q37058678 | ||
| Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection | Q37435631 | ||
| Dual-modality probes for in vivo molecular imaging. | Q37461607 | ||
| The use of fluorescent dyes and probes in surgical oncology | Q37635530 | ||
| Assessment of free dye in solutions of dual-labeled antibody conjugates for in vivo molecular imaging | Q37645745 | ||
| HER2 as a target for breast cancer therapy. | Q37705396 | ||
| Antibody vectors for imaging | Q37720850 | ||
| Multimodal tumor-targeting peptides functionalized with both a radio- and a fluorescent label. | Q37784793 | ||
| Current trends and emerging future of indocyanine green usage in surgery and oncology: a literature review. | Q37864233 | ||
| The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery | Q37865441 | ||
| PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference | Q39523102 | ||
| Imaging prostate cancer lymph node metastases with a multimodality contrast agent | Q39549282 | ||
| Dual functional molecular imaging probe targeting CD20 with PET and optical imaging | Q39840299 | ||
| Novel near-infrared fluorescent integrin-targeted DFO analogue | Q40044646 | ||
| Agonist-antagonist dilemma in molecular imaging: evaluation of a monomolecular multimodal imaging agent for the somatostatin receptor | Q40050040 | ||
| Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe | Q40289086 | ||
| Divergent oriented synthesis for the design of reagents for protein conjugation | Q40781827 | ||
| Multimodal imaging of integrin receptor-positive tumors by bioluminescence, fluorescence, gamma scintigraphy, and single-photon emission computed tomography using a cyclic RGD peptide labeled with a near-infrared fluorescent dye and a radionuclide | Q41815156 | ||
| Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions | Q42249431 | ||
| Molecular imaging with optics: primer and case for near-infrared fluorescence techniques in personalized medicine | Q42269073 | ||
| Characterization of chemical, radiochemical and optical properties of a dual-labeled MMP-9 targeting peptide | Q42850578 | ||
| The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy | Q43059527 | ||
| Simplified syntheses of complex multifunctional nanomaterials | Q43115864 | ||
| Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer | Q43518328 | ||
| PET imaging of somatostatin receptors using [68GA]DOTA-D-Phe1-Tyr3-octreotide: first results in patients with meningiomas | Q43662898 | ||
| Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model | Q43956042 | ||
| Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers | Q45193022 | ||
| Matrix metalloproteinase-9 is a diagnostic marker of heterotopic ossification in a murine model | Q45870213 | ||
| Sentinel node imaging via a nonparticulate receptor-binding radiotracer. | Q46271664 | ||
| Spectral properties of pro-multimodal imaging agents derived from a NIR dye and a metal chelator | Q46667157 | ||
| Targeting of gelatinase activity with a radiolabeled cyclic HWGF peptide. | Q47932905 | ||
| [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation | Q48830083 | ||
| SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action | Q48897339 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| Creative Commons Attribution-NonCommercial 2.0 Generic | Q44128984 | ||
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | molecular imaging | Q1142297 |
| near-infrared spectroscopy | Q30920485 | ||
| fluorescent dye | Q99930106 | ||
| fluorescence spectrometry | Q72368738 | ||
| P304 | page(s) | 261-76 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | Molecular Imaging and Biology | Q6895951 |
| P1476 | title | Dual-labeling strategies for nuclear and fluorescence molecular imaging: a review and analysis | |
| P478 | volume | 14 |
| Q92402599 | A Dual-Modality Linker Enables Site-Specific Conjugation of Antibody Fragments for 18F-Immuno-PET and Fluorescence Imaging |
| Q36497418 | A compact frequency-domain photon migration system for integration into commercial hybrid small animal imaging scanners for fluorescence tomography |
| Q39017820 | A high-affinity near-infrared fluorescent probe to target bombesin receptors |
| Q38985097 | A novel Affibody bioconjugate for dual-modality imaging of ovarian cancer |
| Q50460701 | A novel endoscopic fluorescent clip visible with near-infrared imaging during laparoscopic surgery in a porcine model. |
| Q26822983 | A review of performance of near-infrared fluorescence imaging devices used in clinical studies |
| Q42559733 | Advancing the translation of optical imaging agents for clinical imaging |
| Q55006457 | Advancing theranostics with tumor-targeting peptides for precision otolaryngology. |
| Q41342471 | Assessment of near-infrared fluorophores to study the biodistribution and tumor targeting of an IL13 receptor α2 antibody by fluorescence molecular tomography |
| Q38174552 | Cell tracking using multimodal imaging. |
| Q37638369 | Determining the Performance of Fluorescence Molecular Imaging Devices Using Traceable Working Standards With SI Units of Radiance |
| Q37120903 | Dual PET and Near-Infrared Fluorescence Imaging Probes as Tools for Imaging in Oncology |
| Q47994940 | Dual, Site-Specific Modification of Antibodies by Using Solid-Phase Immobilized Microbial Transglutaminase |
| Q38752324 | Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist |
| Q36848196 | Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis |
| Q30354996 | Hybrid surgical guidance based on the integration of radionuclear and optical technologies |
| Q46198687 | ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment. |
| Q44359350 | Insights into bone metabolism of avian embryos in ovo via 3D and 4D 18F-fluoride positron emission tomography |
| Q28274697 | New Dioxaborolane Chemistry Enables [(18)F]-Positron-Emitting, Fluorescent [(18)F]-Multimodality Biomolecule Generation from the Solid Phase |
| Q37389937 | Photons across medicine: relating optical and nuclear imaging |
| Q26741884 | Preclinical studies and prospective clinical applications for bacteria-targeted imaging: the future is bright |
| Q37541810 | Preventing Radiobleaching of Cyanine Fluorophores Enhances Stability of Nuclear/NIRF Multimodality Imaging Agents |
| Q42204570 | Radioiodination of BODIPY and its application to a nuclear and optical dual functional labeling agent for proteins and peptides |
| Q90541307 | Recent progress on micro- and nano-robots: towards in vivo tracking and localization |
| Q90251255 | Specific Targeting of Somatostatin Receptor Subtype-2 for Fluorescence-Guided Surgery |
| Q89976511 | Study on Absorption Mechanism and Tissue Distribution of Fucoidan |
| Q50520715 | Synthesis of a Fluorescently Labeled 68Ga-DOTA-TOC Analog for Somatostatin Receptor Targeting. |
| Q38213539 | Targeted radionuclide and fluorescence dual-modality imaging of cancer: preclinical advances and clinical translation. |
| Q42961581 | U-SPECT-BioFluo: an integrated radionuclide, bioluminescence, and fluorescence imaging platform |
| Q34550833 | Use of a single hybrid imaging agent for integration of target validation with in vivo and ex vivo imaging of mouse tumor lesions resembling human DCIS |
Search more.